Yeleswaram Krishnaswamy sold RAPP
April 10, 2026 · Form 4 insider transaction
Yeleswaram Krishnaswamy sold 500 shares of Rapport Therapeutics, Inc. at $34.98 per share, a transaction worth $17.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
500
Price
$34.98
Total value
$17.5K
InsiderYeleswaram Krishnaswamy
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 10, 2026
Filing dateApril 14, 2026
Shares owned after286,016
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.